Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02552043
Other study ID # UAMadrid
Secondary ID
Status Completed
Phase N/A
First received September 15, 2015
Last updated August 20, 2016
Start date July 2015
Est. completion date July 2016

Study information

Verified date August 2016
Source Universidad Autonoma de Madrid
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the efficacy of a long-term domiciliary exercise program using the Wii video game platform as a training modality in Cystic Fibrosis (CF) patients. Investigators hypothesize that an exercise program performed by active videogames (AVG) will produce an improvement in exercise tolerance and muscular strength to be maintained over time in young CF patients.


Description:

This is a randomized and longitudinal trial. Participants will be randomize in 2 groups: control group (CG) and experimental group (EG), by the ©GrapfPad Software, Inc. The CG will carry out their routine patient management, and the EG will perform also a domiciliary Pulmonary Rehabilitation program of 30-60 min exercise, 5 days/week during 6 weeks using a Nintendo WiiTM platform with the game EA SPORTS ACTIVE 2.

Before and after we will measure:

1. exercise tolerance using the six minutes walk test (6MWT) and the modified shuttle walk test (MSWT);

2. muscular strength using horizontal jump test (HJT), medicine ball throw (MBT) and handgrip strength (right hand (HGR); left hand (HGL)); and

3. HRQoL using the 3 versions of the Cystic Fibrosis Questionnaire-Revised (CFQ-R 6-11, CFQ-R 14+, CFQ-R Parents).


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date July 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 7 Years to 18 Years
Eligibility Inclusion Criteria:

- Patients with diagnosis of CF, clinically stable without exacerbations of the disease in the previous 6 weeks to the inclusion date.

Exclusion Criteria:

- To present clinical evidence of cardiovascular, neuromuscular or osteo-articular comorbidities that limit the participation in exercise programs.

- Lung transplant candidates and those patients that followed any kind of rehabilitation program 12 months before the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Nintendo Wii exercise program
The aerobic training protocol was designed to improve muscular strength, body endurance and flexibility (involved activities as: running, up the knees, butt kickers, etc.). The game used has a strap pouch to hold the Nunchuk© controller placed on the thigh that detects the lower body movements, and also features a number of exercise options supervised by a virtual personal trainer

Locations

Country Name City State
Spain Centro Superior de estudios Universitarios La SALLE Aravaca Madrid

Sponsors (1)

Lead Sponsor Collaborator
Universidad Autonoma de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary The six-minute walk test (6MWT) The six-minute walk test (6MWT) will perform following the American Thoracic Society recommendations. It is a valid and reliable test in CF children. After recorded basal measurements, patients will be asked to walk as much as possible and standardized encouragement will be given after each minute. Two tests will be performed and the highest walking distance will be recorded. Change from Baseline in the 6-min walk distance at 6 weeks and at 12 months of follow up period Yes
Primary The modified shuttle walk test (MSWT) The modified shuttle walk test (MSWT): consisted of 15 levels in which patients should walk quickly, gradually increasing speed on a 10 meters space. An external audio signal indicates a level shift. Two tests were performed with 30 minutes of rest and the highest walking distance was recorded (MSWD). Valid and reliable test to measure exercise tolerance in CF. Change from Baseline in the modified shuttle walk distance at 6 weeks and at 12 months of follow up period Yes
Secondary Horizontal jump test (HJT) Horizontal jump test (HJT): was made with feet placed at shoulder height. Jump would be invalid if they give an extra step and if they are unbalanced and touch the floor with their hands. Three jumps were made and the highest distance in centimetres was recorded. Horizontal jump assessment is has shown reliable to evaluate the power of the legs. Change from Baseline in the horizontal jump distance at 6 weeks and at 12 months of follow up period Yes
Secondary Medicine ball throw (MBT) Medicine ball throw (MBT): was performed sitting on their knees before throwing the medicine ball (<12 years 2kg; >13 years 3kg) forward like a chest pass with both hands. The furthest distance of the three throws was recorded, with a 1-2 minutes rest between each throw. This instrument is valid and reliable for kindergarten children. Change from Baseline in the throw distance at 6 weeks and at 12 months of follow up period Yes
Secondary Handgrip strength (HG) Handgrip strength will be calculate using a Hand Dynamometer (Jamar® hydraulic USA) of 90Kg. Three trails will given for each hand separately with 30s rest between them and the highest value was recorded in kg (right hand (HGR); left hand (HGL)). The subject is placed sitting with the dynamometer in an angle of 90°. This device is valid and reliable to measure isometric strength and anaerobic endurance. Change from Baseline in handgrip isometric strength at 6 weeks and at 12 months of follow up period Yes
See also
  Status Clinical Trial Phase
Completed NCT04696198 - Thoracic Mobility in Cystic Fibrosis Care N/A
Completed NCT00803205 - Study of Ataluren (PTC124™) in Cystic Fibrosis Phase 3
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03601637 - Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del Phase 3
Terminated NCT02769637 - Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
Recruiting NCT06032273 - Lung Transplant READY CF 2: CARING CF Ancillary RCT N/A
Recruiting NCT06012084 - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis N/A
Recruiting NCT06030206 - Lung Transplant READY CF 2: A Multi-site RCT N/A
Recruiting NCT05392855 - Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF) N/A
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Recruiting NCT04039087 - Sildenafil Exercise: Role of PDE5 Inhibition Phase 2/Phase 3
Recruiting NCT04056702 - Impact of Triple Combination CFTR Therapy on Sinus Disease.
Completed NCT04058548 - Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation N/A
Completed NCT04038710 - Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
Completed NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Recruiting NCT03506061 - Trikafta in Cystic Fibrosis Patients Phase 2
Completed NCT03566550 - Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Recruiting NCT04010253 - Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis N/A